ARA - Lawsuit for Investors in American Renal Associates Holdings Inc. (NYSE: ARA) shares announced by Shareholders Foundation
SAN DIEGO, CA / ACCESSWIRE / April 22, 2019 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in American Renal Associates Holdings, Inc. (NYSE: ARA) shares.
Investors, who purchased shares of American Renal Associates Holdings, Inc. (NYSE: ARA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On March 8, 2019, American Renal Associates Holdings, Inc. announced it would delay the filing of its earnings report for the fiscal year ended December 31, 2018 as it continues to examine reserve computations and other accounting practices that may have an impact on the company's accounts receivable and revenue for fiscal year 2018, as well as previously reported fiscal years ranging from 2014 through 2017.
On March 28, 2019 a lawsuit was filed against American Renal Associates Holdings, Inc. (NYSE: ARA over alleged Securities Laws Violations. The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that issues with American Renal's accounting process for revenue recognition, collections, and related matters would give rise to a U.S. Securities and Exchange Commission ("SEC") investigation into the same, and increased regulatory scrutiny by the SEC, that American Renal's financial statements for the fiscal years 2014, 2015, 2016 and 2017 contained in its Annual Reports for the years ended December 31, 2016, and 2017, and its condensed consolidated financial statements in quarterly reports from 2016 through 2018 were false and could not be relied upon, that American Renal had material weaknesses in its internal control over financial reporting, and that as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
Those who purchased American Renal Associates Holdings, Inc. (NYSE: ARA) shares should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
SOURCE: Shareholders Foundation, Inc.